# FDA Inspection 1164414 - HealthPartners Institute IRB - March 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/healthpartners-institute-irb/2c83a8bd-b037-415d-aaf4-1f92d0ce2792
Source feed: FDA_Inspections

> FDA Inspection 1164414 for HealthPartners Institute IRB on March 14, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1164414
- Company Name: HealthPartners Institute IRB
- Inspection Date: 2022-03-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1164414 - 2022-03-14](https://www.keypedia.com/records/fda_inspections/healthpartners-institute-irb/34174035-5780-43fd-9698-41f57dcf46df)
- [FDA Inspection 1090898 - 2019-05-28](https://www.keypedia.com/records/fda_inspections/healthpartners-institute-irb/4d4d3b0f-9725-4a4a-84dc-830005ced4d7)
- [FDA Inspection 831831 - 2013-05-13](https://www.keypedia.com/records/fda_inspections/healthpartners-institute-irb/3fdee6ea-62fb-4f63-ae2e-d277ad5cf726)
- [FDA Inspection 627621 - 2009-10-29](https://www.keypedia.com/records/fda_inspections/healthpartners-institute-irb/d8028af3-9773-4272-a86b-081257d310c1)

Company: https://www.keypedia.com/companies/healthpartners-institute-irb/62b8d4dd-4b68-4e32-9b08-6fb2845f305f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c